"The use of omega-3 fatty acids for the secondary prevention of cardiovascular (CV) events has been endorsed by the American Heart Association. A number of key epidemiologic and randomized trials have been the basis for this recommendation. Initially, the GISSI-Prevenzione and JELIS trials demonstrated significant reductions in CV events with the use of omega-3 fatty acids. More recently,the OMEGA, Alpha Omega, and Kowey et al. studies examining omega-3 supplementation in atrial fibrillation have shown conflicting results. Although more recent trials have not shown the robust benefits that were seen in the earlier ones, the balance of evidence still favor the beneficial effects of omega-3 fatty acids. We would recommend the continuation of omega-3 fatty acids in patients with CV disease and in particular heart failure.
John H Lee; Omega-3 Fatty Acids and Cardiovascular Disease" High-impact journals are those considered to be highly influential in their respective fields. The impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing journals of similar kind. It reflects the average number of citations to recent articles published in science and social science journals in a particular year or period, and is frequently used as a proxy for the relative importance of a journal within its field. It is first devised by Eugene Garfield, the founder of the Institute for Scientific Information. The impact factor of a journal is evaluated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Last date updated on September, 2020